BOGOTA, Colombia – Less than two months after Peru issued technical standards to register and re-register biosimilars, the new regulations are generating buzz in the country's biopharma space.

HONG KONG – Efforts are under way in Latin America to speed up the development of a vaccine for the Zika virus that has ran rampant in parts of the continent, most notably Brazil.

HONG KONG – Novartis AG pulled out of negotiations with the government of Colombia to determine a price for the leukemia drug Glivec (imatinib). Discussions had been initiated to prevent the issuance of a mandatory license. (See BioWorld Today, April 22, 2016.)

BOGOTA, Colombia – Novartis AG is working against the clock in Colombia in a bid to prevent the Colombian government from issuing a mandatory license for the blockbuster cancer drug Glivec (imatinib).

BOGOTA, Colombia — Boston Scientific do Brasil Ltda., the Brazilian subsidiary of the med-tech multinational, has emerged as the first company linked to an investigation into possible cartel activities in the largest market in Latin America.